Two Sigma Investments’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
ACM
AIC
Two Sigma Investments's ABEO Position: Q3 2026 in Review
Two Sigma Investments increased its Abeona Therapeutics (ABEO) stake by 54% in Q3 2026, buying an estimated $273K and bringing the position to 124,674 shares worth $655K. The position accounts for ﹤0.01% of the portfolio, ranked #3871.
Two Sigma Investments first reported a position in ABEO in Q2 2019 and has held it in 7 quarters since. 115 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.
- Two Sigma Investments held 124,674 shares of Abeona Therapeutics worth $655K as of Q3 2026.
- Two Sigma Investments bought 43,937 Abeona Therapeutics shares in Q3 2026, an estimated $273K.
- Abeona Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #3871 holding.
- Two Sigma Investments first reported a position in Abeona Therapeutics in Q2 2019 and has held it in 7 quarters since.
- 115 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.